RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
42 hedge funds and large institutions have $11.2M invested in Rubius Therapeutics, Inc in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 24 closing their positions.
Holders
42
Holders Change
-20
Holders Change %
-32.26%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
10
Reduced
15
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$222K |
2 |
2
Renaissance Technologies
New York
|
$35K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$13.1K |
4 |
E
4
Ergoteles
New York
|
$9.94K |
5 |
VF
5
Virtu Financial
New York
|
$12K |